SLN
Silence Therapeutics·NASDAQ
--
--(--)
--
--(--)
SLN fundamentals
During Q4 2025, Silence Therapeutics (SLN) reported revenue of 34.00K, a YoY change of -99.87%. Net income was -11.77M, a YoY change of -195.68%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 2.57M -- | 3.20M -- | 4.34M -- | 3.73M -- | 4.25M +65.50% | 4.61M +43.86% | 7.53M +73.51% | 4.43M +18.82% | 3.75M -11.71% | 5.75M +24.86% | 14.07M +86.94% | 11.57M +161.14% | 3.42M -8.95% | 2.67M -53.52% | 15.70M +11.59% | 756.00K -93.47% | 1.50M -56.17% | 25.30M +846.07% | 142.00K -99.10% | 224.00K -70.37% | 159.00K -89.39% | 34.00K -99.87% | 559.00K -- |
Sales and Services Revenue | 2.57M -- | 3.20M -- | 4.34M -- | 3.73M -- | 4.25M +65.50% | 4.61M +43.86% | 7.53M +73.51% | 4.43M +18.82% | 3.75M -11.71% | 5.75M +24.86% | 14.07M +86.94% | 11.57M +161.14% | 3.42M -8.95% | -- -- | 15.70M +11.59% | 756.00K -93.47% | 1.50M -56.17% | 25.30M -- | 142.00K -99.10% | 224.00K -70.37% | 159.00K -89.39% | 34.00K -99.87% | 559.00K -- |
Cost of Revenue | 3.01M -- | 1.96M -- | 2.12M -- | 2.52M -- | 2.76M -8.23% | 2.76M +41.01% | 2.99M +41.12% | 2.86M +13.53% | 2.67M -3.57% | 4.66M +69.06% | 5.61M +87.43% | 3.60M +25.78% | 1.96M -26.36% | 1.72M -63.20% | 2.80M -50.07% | 3.33M -7.36% | 3.64M +85.40% | 2.04M +18.82% | 54.00K -98.07% | 85.00K -97.45% | 64.00K -98.24% | 12.00K -99.41% | 215.00K -- |
Cost of Goods and Services | -- -- | 5.14M -- | -- -- | -- -- | -- -- | 10.07M +95.84% | -- -- | -- -- | -- -- | 13.14M +30.54% | -- -- | -- -- | 1.96M -- | -- -- | 2.80M -- | 3.33M -- | 3.64M +85.40% | 2.04M -- | 54.00K -98.07% | 85.00K -97.45% | 64.00K -98.24% | 12.00K -99.41% | 215.00K -- |
Gross Profit | -443.19K -- | 1.25M -- | 2.22M -- | 1.21M -- | 1.49M +435.54% | 1.85M +48.33% | 4.53M +104.50% | 1.57M +29.83% | 1.09M -26.85% | 1.09M -40.93% | 8.46M +86.62% | 7.97M +407.76% | 1.45M +33.73% | -- -- | 12.90M +52.46% | -2.58M -132.32% | -2.14M -247.18% | 23.27M -- | 88.00K -99.32% | 139.00K +105.39% | 95.00K +104.44% | 22.00K -99.91% | 344.00K -- |
Other Operating Income | -- -- | 2.04M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 11.92M -- | 13.15M -- | 15.10M -- | 19.06M -- | 18.03M +51.29% | 17.06M +29.68% | 17.58M +16.42% | 18.71M -1.84% | 16.25M -9.87% | 14.33M -15.98% | 23.49M +33.58% | 22.53M +20.46% | 16.97M +4.38% | -- -- | 18.48M -21.32% | 20.81M -7.64% | 27.86M +64.19% | 27.62M -- | 28.50M +54.20% | 24.10M +15.81% | 26.34M -5.45% | 12.48M -54.80% | 91.42M -- |
Selling, General and Administrative Expenses | 3.44M -- | 8.41M -- | 5.17M -- | 7.42M -- | 7.37M +113.97% | 7.30M -13.16% | 7.58M +46.63% | 5.53M -25.49% | 6.49M -11.98% | 4.19M -42.66% | 7.98M +5.20% | 6.50M +17.53% | 6.05M -6.70% | -- -- | 6.63M -16.83% | 7.01M +7.82% | 7.70M +27.15% | 5.54M -- | 7.68M +15.81% | 5.13M -26.79% | 5.79M -24.71% | 3.73M -32.62% | 22.34M -- |
General and Administrative Expenses | -- -- | 19.10M -- | -- -- | -- -- | -- -- | 27.01M +41.39% | -- -- | -- -- | -- -- | 23.68M -12.32% | -- -- | -- -- | 6.05M -- | -- -- | 6.63M -- | 7.01M -- | 7.70M +27.15% | 5.54M -- | 7.68M +15.81% | 5.13M -26.79% | 5.79M -24.71% | 3.73M -32.62% | 22.34M -- |
Research and Development Expenses | 4.48M -- | 8.97M -- | 10.29M -- | 11.28M -- | 10.66M +137.96% | 9.75M +8.78% | 10.00M -2.81% | 13.17M +16.84% | 9.77M -8.41% | 10.14M +4.01% | 15.51M +55.10% | 16.03M +21.70% | 10.91M +11.74% | -- -- | 11.85M -23.63% | 13.80M -13.91% | 20.16M +84.74% | 22.08M -- | 20.81M +75.71% | 17.65M +27.86% | 20.54M +1.91% | 8.75M -60.37% | 67.75M -- |
Other Operating Expenses | 3.99M -- | -4.22M -- | -357.29K -- | 357.58K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | 1.32M -- | 0 -- | 0 -- | -- -- |
Operating Income | -12.36M -- | -9.87M -- | -12.89M -- | -17.85M -- | -16.55M -33.84% | -15.21M -54.10% | -13.05M -1.27% | -17.14M +3.99% | -15.17M +8.35% | -13.24M +12.94% | -15.03M -15.16% | -14.56M +15.02% | -15.51M -2.27% | -- -- | -5.58M +62.86% | -23.39M -60.62% | -30.00M -93.40% | -4.35M -- | -28.41M -409.03% | -23.96M -2.46% | -26.24M +12.51% | -12.46M -186.33% | -91.08M -- |
Non-Operating Income (Loss) | 36.18K -- | -8.13M -- | -729.76K -- | 302.35K -- | 312.50K +763.78% | 48.60K +100.60% | 460.32K +163.08% | 813.64K +169.10% | 4.78M +1430.24% | -4.94M -10261.08% | -648.14K -240.80% | -702.81K -186.38% | 2.49M -47.95% | -- -- | 3.51M +642.02% | 3.86M +649.37% | -5.50M -320.87% | 16.98M -- | -121.00K -103.44% | -3.38M -187.57% | 5.29M +196.16% | 691.00K -95.93% | 2.48M -- |
Gain (Loss) on Other Investment | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 245.16K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gain (Loss) on Foreign Currency Exchange | -- -- | -7.06M -- | -- -- | -- -- | -- -- | -59.40K +99.16% | -- -- | -- -- | -- -- | 1.26M +2226.69% | -- -- | -- -- | -- -- | -- -- | 351.00K -- | -222.00K -- | -11.40M -- | 11.91M -- | -3.77M -1173.79% | -6.61M -2878.83% | 1.93M +116.97% | -19.00K -100.16% | -8.47M -- |
Other Non-Operating Income (Loss) | 36.18K -- | -1.22M -- | -729.76K -- | 302.35K -- | 312.50K +763.78% | 105.30K +108.64% | 460.32K +163.08% | 813.64K +169.10% | 4.78M +1430.24% | -6.42M -6194.70% | -648.14K -240.80% | -702.81K -186.38% | -- -- | -- -- | 3.16M +587.86% | 4.08M +680.96% | 5.90M -- | 5.07M -- | 3.65M +15.37% | 3.23M -20.84% | 3.35M -43.15% | 710.00K -85.98% | 10.94M -- |
Net Interest Expense | -- -- | -154.38K -- | -- -- | -- -- | -- -- | -2.70K +98.25% | -- -- | -- -- | -- -- | 28.98K +1173.51% | -- -- | -- -- | -2.49M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Interest Expense | -- -- | 21.86K -- | -- -- | -- -- | -- -- | 10.80K -50.59% | -- -- | -- -- | -- -- | 56.76K +425.57% | -- -- | -- -- | 9.77K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Interest Income | -- -- | 176.24K -- | -- -- | -- -- | -- -- | 13.50K -92.34% | -- -- | -- -- | -- -- | 27.78K +105.76% | -- -- | -- -- | 2.50M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Pretax Income From Continuing Operations | -12.33M -- | -18.00M -- | -13.62M -- | -17.54M -- | -16.23M -31.70% | -15.16M +15.78% | -12.59M +7.54% | -16.32M +6.97% | -10.38M +36.04% | -18.18M -19.92% | -15.68M -24.51% | -15.26M +6.48% | -13.02M -25.40% | -19.07M -4.93% | -2.07M +86.81% | -19.53M -27.93% | -35.49M -172.59% | 12.63M +166.20% | -28.53M -1279.59% | -27.34M -40.03% | -20.96M +40.96% | -11.77M -193.22% | -88.60M -- |
Income Tax Expense | -596.95K -- | -1.00M -- | -2.00M -- | -1.49M -- | -2.86M -379.05% | -2.42M -142.04% | -2.48M -24.14% | -1.80M -20.80% | -2.48M +13.45% | -1.55M +35.79% | -3.05M -22.99% | -2.04M -13.53% | -2.94M -18.98% | -705.96K +54.58% | 244.00K +107.99% | 228.00K +111.15% | 49.00K +101.66% | 324.00K +145.89% | -- -- | 10.00K -95.61% | 1.00K -97.96% | -- -- | -- -- |
Current Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -8.79M -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 845.00K -- | -- -- | -- -- | -- -- | 11.00K -98.70% | -- -- |
Deferred Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- |
Income Tax Adjustments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 484.29K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -11.73M -- | -17.00M -- | -11.62M -- | -16.05M -- | -13.37M -14.02% | -12.74M +25.06% | -10.11M +12.99% | -14.52M +9.55% | -7.91M +40.87% | -16.62M -30.51% | -12.62M -24.89% | -13.22M +8.96% | -10.08M -27.41% | -18.37M -10.49% | -2.31M +81.68% | -19.75M -49.45% | -35.54M -252.74% | 12.30M +166.99% | -28.53M -1134.00% | -27.35M -38.47% | -20.96M +41.04% | -11.77M -195.68% | -88.61M -- |
Net Income Attributable to Owners of the Company | -11.73M -- | -17.00M -- | -11.62M -- | -16.05M -- | -13.37M -14.02% | -12.74M +25.06% | -10.11M +12.99% | -14.52M +9.55% | -7.91M +40.87% | -16.62M -30.51% | -12.62M -24.89% | -13.22M +8.96% | -10.08M -27.41% | -- -- | -2.31M +81.68% | -19.75M -49.45% | -35.54M -252.74% | 12.30M -- | -28.53M -1134.00% | -27.35M -38.47% | -20.96M +41.04% | -11.77M -195.68% | -88.61M -- |
Net Income Attributable to Common Stockholders | -11.73M -- | -17.00M -- | -11.62M -- | -16.05M -- | -13.37M -14.02% | -12.74M +25.06% | -10.11M +12.99% | -14.52M +9.55% | -7.91M +40.87% | -16.62M -30.51% | -12.62M -24.89% | -13.22M +8.96% | -10.08M -27.41% | -- -- | -2.31M +81.68% | -19.75M -49.45% | -35.54M -252.74% | 12.30M -- | -28.53M -1134.00% | -27.35M -38.47% | -20.96M +41.04% | -11.77M -195.68% | -88.61M -- |
Other Comprehensive Income | -15.51K -- | -137.99K -- | -729.76K -- | 106.31K -- | 24.25K +256.37% | -328.05K -137.74% | 102.59K +114.06% | 126.48K +18.98% | 562.27K +2219.01% | -172.70K +47.36% | -48.24K -147.02% | -190.63K -250.72% | 72.06K -87.18% | -5.10K +97.05% | -57.00K -18.16% | 186.00K +197.57% | 7.67M +10549.07% | -8.86M -173701.30% | 3.70M +6584.21% | 6.68M +3491.40% | -1.67M -121.75% | 97.00K +101.09% | 8.80M -- |
Total Comprehensive Income | -11.75M -- | -17.13M -- | -12.35M -- | -15.95M -- | -13.35M -13.66% | -13.06M +23.75% | -10.00M +18.97% | -14.39M +9.74% | -7.35M +44.97% | -16.79M -28.55% | -12.67M -26.65% | -13.41M +6.84% | -10.00M -36.19% | -18.37M -9.38% | -2.37M +81.30% | -19.57M -45.94% | -27.87M -178.57% | 3.44M +118.74% | -24.83M -948.29% | -20.67M -5.65% | -22.63M +18.81% | -11.67M -439.04% | -79.81M -- |
Total Comprehensive Income Attributable to Owners of the Company | -11.75M -- | -17.13M -- | -12.35M -- | -15.95M -- | -13.35M -13.66% | -13.06M +23.75% | -10.00M +18.97% | -14.39M +9.74% | -7.35M +44.97% | -16.79M -28.55% | -12.67M -26.65% | -13.41M +6.84% | -10.00M -36.19% | -- -- | -2.37M +81.30% | -19.57M -45.94% | -27.87M -178.57% | 3.44M -- | -24.83M -948.29% | -20.67M -5.65% | -22.63M +18.81% | -11.67M -439.04% | -79.81M -- |
Basic EPS | -0.14 -- | -0.2 -- | -0.13 -- | -0.18 -- | -0.15 -7.14% | -0.14 +30.00% | -0.11 +15.38% | -0.16 +11.11% | -0.08 +46.67% | -0.15 -7.14% | -0.12 -9.09% | -0.12 +25.00% | -0.09 -12.50% | -0.15 -- | -0.02 +83.33% | -0.14 -16.67% | -0.25 -177.78% | 0.09 +160.00% | -0.2 -900.00% | -0.19 -35.71% | -0.15 +40.00% | -0.08 -188.89% | -0.62 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.09 -- | -- -- | -0.02 -- | -0.14 -- | -0.25 -177.78% | -- -- | -0.2 -900.00% | -0.19 -35.71% | -0.15 +40.00% | -- -- | -- -- |
Diluted EPS | -0.14 -- | -- -- | -0.13 -- | -0.18 -- | -0.15 -7.14% | -- -- | -0.11 +15.38% | -0.16 +11.11% | -0.08 +46.67% | -- -- | -0.12 -9.09% | -0.12 +25.00% | -0.09 -12.50% | -- -- | -0.02 +83.33% | -0.14 -16.67% | -0.25 -177.78% | -- -- | -0.2 -900.00% | -0.19 -35.71% | -0.15 +40.00% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.09 -- | -- -- | -0.02 -- | -0.14 -- | -0.25 -177.78% | -- -- | -0.2 -900.00% | -0.19 -35.71% | -0.15 +40.00% | -- -- | -- -- |
You can ask Aime
What is the market's earnings forecast for Silence Therapeutics next quarter?What factors drove the changes in Silence Therapeutics's revenue and profit?What guidance did Silence Therapeutics's management provide for the next earnings period?What were the key takeaways from Silence Therapeutics’s earnings call?What were the key takeaways from Silence Therapeutics's earnings call?What does Silence Therapeutics do and what are its main business segments?What is Silence Therapeutics's gross profit margin?Did Silence Therapeutics beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
